{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:48:57Z","timestamp":1790668137319,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T00:00:00Z","timestamp":1227484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Project grant from the British Heart Foundation","award":["PG\/06\/126\/21673"],"award-info":[{"award-number":["PG\/06\/126\/21673"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Patients with advanced liver disease are at increased risk of cardiovascular events, especially following orthotopic liver transplantation (OLT). Coronary artery calcification (CAC) is a novel and independent predictor of cardiovascular risk, but its prevalence and utility in patients with cirrhosis are unknown. The aim of this study was to define the prevalence of CAC and its association with markers of disease severity and standard measures of cardiovascular risk in a large cohort of patients undergoing OLT assessment. A single-center, prospective, observational study of 147 consecutive patients undergoing assessment for OLT was performed. CAC scores were derived with the Agatston method from thoracic computed tomography scans and correlated with cardiovascular risk factors and measures of liver disease severity. There were 101 patients (66 males) with a mean age of 53.2 years; 46 patients were excluded because the CAC score was not reported. The median CAC score was 40 HU (range, 0-3533). Correlations were identified between the CAC score and age (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.477;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.001), male sex (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.262;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.008), family history of cardiovascular disease (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.208;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.036), Framingham risk score (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.621;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.001), Model for End-Stage Liver Disease score (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.221;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.027), systolic blood pressure (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.285;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.004), diastolic blood pressure (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.267;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.007), cytomegalovirus status (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.278;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.005), fasting glucose (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.330;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.001), number of coronary vessels involved (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.899;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.001), and components of the metabolic syndrome (<\/jats:bold>\n                                 <jats:bold>\n                                    r\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.226;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.026). After multivariate analysis, age, systolic blood pressure, fasting glucose, number of features of metabolic syndrome, and number of vessels involved remained significantly associated with CAC. In conclusion, this study identified a high prevalence of occult coronary artery disease in patients undergoing OLT assessment and identified a strong relationship between CAC scores and a limited number of specific cardiovascular risk factors. The usefulness of these factors in predicting perioperative and postoperative cardiovascular events in patients undergoing OLT requires prospective evaluation.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21540","type":"journal-article","created":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T15:23:54Z","timestamp":1227540234000},"page":"1725-1731","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":86,"title":["Prevalence of Coronary Artery Calcification in Patients Undergoing Assessment for Orthotopic Liver Transplantation"],"prefix":"10.1097","volume":"14","author":[{"given":"Norma C.","family":"McAvoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20250326","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00007890-200203270-00012","article-title":"Cardiovascular morbidity and mortality after orthotopic liver transplantation.","volume":"73","author":"Johnston","year":"2002","journal-title":"Transplantation"},{"issue":"suppl 1","key":"R2-5-20250326","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/lt.500060511","article-title":"Coronary artery disease and liver transplantation: the state of the art.","volume":"6","author":"Plotkin","year":"2000","journal-title":"Liver Transpl"},{"key":"R3-5-20250326","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1399-0012.1995.tb00368.x","article-title":"Cardiovascular complications following liver transplantation.","volume":"9","author":"Dec","year":"1995","journal-title":"Clin Transplant"},{"key":"R4-5-20250326","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/jlts.2001.27084","article-title":"Analysis of causes of death in liver transplant recipients who survived more than 3 years.","volume":"7","author":"Pruthi","year":"2001","journal-title":"Liver Transpl"},{"key":"R5-5-20250326","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0002-9610(02)00826-7","article-title":"Immunosuppression impact on longterm cardiovascular complications after liver transplantation.","volume":"183","author":"Rabkin","year":"2002","journal-title":"Am J Surg"},{"key":"R6-5-20250326","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinte.164.12.1285","article-title":"Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and metaanalysis.","volume":"164","author":"Pletcher","year":"2004","journal-title":"Arch Intern Med"},{"key":"R7-5-20250326","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices.","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R8-5-20250326","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with endstage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R9-5-20250326","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/01.tp.0000235516.99977.95","article-title":"Developing a prognostic model for 90day mortality after liver transplantation based on pretransplant recipient factors.","volume":"82","author":"Lewsey","year":"2006","journal-title":"Transplantation"},{"key":"R10-5-20250326","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R11-5-20250326","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories.","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"R12-5-20250326","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography.","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"R13-5-20250326","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R15-5-20250326","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/0002-8703(94)90378-6","article-title":"Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events.","volume":"127","author":"Afridi","year":"1994","journal-title":"Am Heart J"},{"key":"R16-5-20250326","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","article-title":"Elevated levels of interleukin6 in unstable angina.","volume":"94","author":"Biasucci","year":"1996","journal-title":"Circulation"},{"key":"R17-5-20250326","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/00007890-199604270-00011","article-title":"Twodimensional and dobutamine stress echocardiography in the preoperative assessment of patients with endstage liver disease prior to orthotopic liver transplantation.","volume":"61","author":"Donovan","year":"1996","journal-title":"Transplantation"},{"key":"R18-5-20250326","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","article-title":"Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.","volume":"98","author":"TiukinhoyLaing","year":"2006","journal-title":"Am J Cardiol"},{"key":"R19-5-20250326","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation.","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J Hepatol"},{"key":"R20-5-20250326","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0002-9149(92)90495-K","article-title":"Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography.","volume":"69","author":"Giroud","year":"1992","journal-title":"Am J Cardiol"},{"key":"R21-5-20250326","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between endstage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R22-5-20250326","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00774-005-0668-6","article-title":"Vascular calcification in chronic kidney disease.","volume":"24","author":"Jono","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"R23-5-20250326","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronaryartery calcification in young adults with endstage renal disease who are undergoing dialysis.","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R24-5-20250326","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/j.1600-6143.2007.01903.x","article-title":"Determinants of coronary artery calcification progression in renal transplant recipients.","volume":"7","author":"Schankel","year":"2007","journal-title":"Am J Transplant"},{"key":"R25-5-20250326","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004872-200404000-00014","article-title":"Agedependent associations between blood pressure and coronary artery calcification in asymptomatic adults.","volume":"22","author":"Bielak","year":"2004","journal-title":"J Hypertens"},{"key":"R26-5-20250326","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jacc.2006.04.089","article-title":"Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (MultiEthnic Study of Atherosclerosis).","volume":"48","author":"Wang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R27-5-20250326","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9149(00)01000-6","article-title":"Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events.","volume":"86","author":"Wong","year":"2000","journal-title":"Am J Cardiol"},{"key":"R28-5-20250326","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2337\/dc07-1042","article-title":"Insulin resistance, metabolic syndrome and subclinical atherosclerosis: the MultiEthnic Study of Atherosclerosis (MESA).","volume":"30","author":"Bertoni","year":"2007","journal-title":"Diabetes Care"},{"key":"R29-5-20250326","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.","volume":"55","author":"Allocca","year":"2006","journal-title":"Gut"},{"key":"R30-5-20250326","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.0000084505.54603.C7","article-title":"Human cytomegalovirus seropositivity is associated with impaired vascular function.","volume":"108","author":"GrahameClarke","year":"2003","journal-title":"Circulation"},{"key":"R31-5-20250326","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2005.02.088","article-title":"Coronary calcification, coronary disease risk factors, Creactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study.","volume":"46","author":"Arad","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R32-5-20250326","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.291.2.210","article-title":"Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.","volume":"291","author":"Greenland","year":"2004","journal-title":"JAMA"},{"key":"R33-5-20250326","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1161\/01.CIR.0000068341.61180.55","article-title":"Electronbeam tomography coronary artery calcium and cardiac events: a 37month followup of 5635 initially asymptomatic low to intermediaterisk adults.","volume":"107","author":"Kondos","year":"2003","journal-title":"Circulation"},{"key":"R34-5-20250326","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1148\/radiol.2283021006","article-title":"Prognostic value of cardiac risk factors and coronary artery calcium screening for allcause mortality.","volume":"228","author":"Shaw","year":"2003","journal-title":"Radiology"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21540","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21540","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200812000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:34:33Z","timestamp":1743273273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200812000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21540","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}